To date, the State of St. Paul records 159,925 likely cases of illness and has confirmed 71 deaths
An 11 year old girl was the first fatal victim dense In capital In 2025, according to the municipal health secretariat of San Paolo (SMS-SP). The child, who lived in the region of Ermelino Matarazzo, east of the city, died on January 30th.
From the beginning, the state of Saint Paul records 159,925 suspicious cases of dense and 71 deaths due to the disease. The municipalities of Mogi Guaçu, with eight dead, Jaboticabal, with six, and San José do rio preto, even with six. The data come from the Arbovirores group of the government of the State of San Paolo.
SMS continues to find out if the child had a history of health problems. “People with chronic diseases such as diabetes, anemia, asthma, cardiac diseases, among others, have a greater risk of aggravation”, explains Renato Kfouri, pediatric infectologist and vice -president of the Brazilian society of immunizations (Sbim).
Brazil has an immunizer available against the disease, the QDENGA vaccine, made by the Japanese pharmacist. He began to be offered in July 2023 by the private network in Brazil and, in December of the same year, he was incorporated Unified Health System (Sus).
The country has become the first in the world to offer the vaccine in the public network. Due to the limited number of doses, however, initially only children and adolescents from 10 to 14 years of 521 municipalities have been selected by the Ministry of Health to receive the Sus vaccine. The immunner must be taken in two doses. According to the manufacturer, the complete vaccination scheme showed 80.2% effectiveness in reducing Dengue cases after 12 months and a reduction of 90.4% of hospitalizations after 18 months.
“There is the prospect of controlling the disease with the vaccine, but we need a higher percentage of the population to be immunized,” says Kfouri.
In January 2025, the Estadão He showed that after almost a year from the start of the vaccination campaign, only 10.65% of children and teenagers aged between 10 and 14 years of the State of San Paolo Completed the vaccination scheme with both dosessecond State Secretariat data of Saint Paul of San Paolo (SES-SP).
“What we don’t have so far, unfortunately, It is a high amount of doses To vaccinate many children, “adds Kfouri”. [do imunizante] For those who can already immunize themselves. “
According to the infectoologist, the vaccine is contraindicated for pregnant women and immunocompromese people, such as transplanted, HIV -positive or patients with some kind of cancer.
In January of this year, the Butantan Institute Started the production of his vaccine against the disease. The expectation is to produce doses of 1 million in 2025 and another 100 million in the next three years. The immunner, however, has not yet been approved by National Health Surveillance Agency (Anvisa). The agency’s opinion should be released in mid -March. The vaccine can only be distributed if approved.
Source: Terra
Ben Stock is a lifestyle journalist and author at Gossipify. He writes about topics such as health, wellness, travel, food and home decor. He provides practical advice and inspiration to improve well-being, keeps readers up to date with latest lifestyle news and trends, known for his engaging writing style, in-depth analysis and unique perspectives.
